Artwork

Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep72: Investing in the Future of Digital Therapeutics: Opportunities and Challenges in the Market

37:25
 
Share
 

Manage episode 373589728 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

Artwork
iconShare
 
Manage episode 373589728 series 2857558
Content provided by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mission Based Media, Ltd and Digital Health Today with Eugene Borukhovich or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture funds exclusively dedicated to the digital health space. In 2018, Astellas continued its endeavor in digital health by forming the Rx Plus Digital Fund with DigiTx Partners as its investment manager.

In this episode, we cover:

  • What are the challenges faced by digital therapeutics in terms of distribution and clinical workflow?
  • What hypothesis does DigiTx on DTx?
  • What are the benefits of standalone vs drug+? Are DigiTx tracking any other modalities?
  • What lessons have DigiTx learned so far?
  • What will be the drivers for new capital injections in DTx especially? What are investors looking for ?
  • What will the drivers of success going forward be for DTx?
  • How will the role of doctors, nurse & pharmacists change in order for the industry overall to scale PDT's?

Guest Links and Resources:

Host Links:

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:

> Presenting Partner: Amalgam Rx

> Contributing Partners and Sponsors: LSI | Bayer G4A | Lindus Health

Follow Digital Health Today:

Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:

Browse Shows | LinkedIn | Twitter | Facebook | Instagram

  continue reading

102 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide